✦ LIBER ✦

Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

✍ Scribed by Juerg Nussberger; Alan H. Gradman; Roland E. Schmieder; Robert L. Lins; William B. White; Margaret Prescott; Yanntong Chiang

Book ID: 116209261
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 66 KB
Volume: 18
Category: Article
ISSN: 0895-7061
DOI: 10.1016/j.amjhyper.2005.03.641

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma renin and the antihypertensive ef

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension

✍ J. Nussberger; A. H. Gradman; R. E. Schmieder; R. L. Lins; Y. Chiang; M. F. Pres 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Antihypertensive efficacy, safety, and t

Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis

✍ Matthew R. Weir; Christopher Bush; David R. Anderson; Jack Zhang; Deborah Keefe; 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 1017 KB

Long-Term Safety and Tolerability of the

Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension

✍ Domenic Sica, Alan H. Gradman, Ole Lederballe, Rainer E. Kolloch, Jack Zhang, De 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 175 KB

EFFECTS OF THE ORAL DIRECT RENIN INHIBIT

EFFECTS OF THE ORAL DIRECT RENIN INHIBITOR ALISKIREN ON PLASMA BNP CONCENTRATION IN PATIENTS WITH SYMPTOMATIC HEART FAILURE ACCORDING TO BACKGROUND DOSE OF ACE INHIBITOR

✍ John JV McMurray; Claudio Gimpelewicz; Roberto Latini; Aldo P. Maggioni; Bertram 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Evaluation of the dose—response relation

Evaluation of the dose—response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension

✍ Juan G. Puig; Heribert Schunkert; Addison A. Taylor; Sam Boye; James Jin; Debora 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB